PRF Technologies (PRFX) Enterprise Value (QoQ) (2020 - 2024)
PRF Technologies (PRFX) Enterprise Value (QoQ) (2020 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 35.56% |
| Mar 31, 2024 | 46.00% |
| Dec 31, 2023 | 6.55% |
| Sep 30, 2023 | -39.39% |
| Jun 30, 2023 | 24.40% |
| Mar 31, 2023 | 19.94% |
| Dec 31, 2022 | 21.56% |
| Sep 30, 2022 | 6.41% |
| Jun 30, 2022 | 16.31% |
| Mar 31, 2022 | -0.21% |
| Dec 31, 2021 | 9.82% |
| Sep 30, 2021 | -2.99% |
| Jun 30, 2021 | 8.40% |
| Mar 31, 2021 | -23.98% |
| Dec 31, 2020 | 11.54% |
| Sep 30, 2020 | -3,122.36% |
| Jun 30, 2020 | 41.55% |
| Mar 31, 2020 | 0.00% |